BioNTech SE - ADR vs EHang Holdings Ltd - ADR — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while EHang Holdings Ltd - ADR trades at $5.85 (market cap $437.63M). The key difference: BioNTech SE - ADR is far larger — about 53.3× EHang Holdings Ltd - ADR's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, EHang Holdings Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | EH | |
|---|---|---|
Market Cap | $23.31B | $437.63M |
Sector | Health | Industrials |
52-Week High | $119.34 | $19.44 |
52-Week Low | $83.89 | $4.90 |
Enterprise Value | $6.60B | $376.84M |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →